Scarica l'app Stockscreener
1.78
7.88%
0.13
Dopo l'orario di chiusura:
1.76
-0.02
-1.12%
Precedente Chiudi:
$1.65
Aprire:
$1.75
Volume 24 ore:
8.31M
Relative Volume:
1.54
Capitalizzazione di mercato:
$10.37M
Reddito:
$14.64M
Utile/perdita netta:
$-13.74M
Rapporto P/E:
-0.2448
EPS:
-7.27
Flusso di cassa netto:
$-5.04M
1 W Prestazione:
+95.58%
1M Prestazione:
+181.65%
6M Prestazione:
+191.76%
1 anno Prestazione:
+260.18%
Intervallo 1D:
$1.65
$2.13
Intervallo di 1 settimana:
$0.8651
$2.13
Portata 52W:
$0.44
$2.13
Novabay Pharmaceuticals Inc Stock (NBY) Company Profile
Nome
Novabay Pharmaceuticals Inc
Settore
Industria
Telefono
510-899-8800
Indirizzo
2000 Powell Street, Suite 1150, Emeryville, CA
Confronta NBY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NBY
Novabay Pharmaceuticals Inc
|
1.78 | 9.61M | 14.64M | -13.74M | -5.04M | -7.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2019-09-18 | Iniziato | Ladenburg Thalmann | Buy |
| 2018-07-06 | Reiterato | H.C. Wainwright | Buy |
| 2017-11-15 | Reiterato | Laidlaw | Buy |
| 2017-06-05 | Iniziato | ROTH Capital | Buy |
| 2017-03-27 | Iniziato | Laidlaw | Buy |
| 2017-02-06 | Iniziato | Rodman & Renshaw | Buy |
| 2016-03-07 | Downgrade | Maxim Group | Buy → Hold |
| 2015-12-14 | Reiterato | Maxim Group | Buy |
| 2015-04-30 | Ripresa | Maxim Group | Buy |
| 2013-03-06 | Iniziato | Ascendiant Capital Markets | Strong Buy |
| 2008-01-03 | Iniziato | Dawson James | Speculative Buy |
Mostra tutto
Novabay Pharmaceuticals Inc Borsa (NBY) Ultime notizie
Should you wait for a breakout in NovaBay Pharmaceuticals Inc.2025 Technical Patterns & Precise Buy Zone Identification - Newser
Is NovaBay Pharmaceuticals Inc. still worth holding after the dipWeekly Risk Report & High Conviction Trade Alerts - Newser
Price action breakdown for NovaBay Pharmaceuticals Inc.Market Volume Report & High Accuracy Trade Signal Alerts - Newser
Live market analysis of NovaBay Pharmaceuticals Inc.2025 Price Targets & Smart Allocation Stock Reports - Newser
How to recover losses in NovaBay Pharmaceuticals Inc. stockMarket Movement Recap & AI Forecasted Entry and Exit Points - Newser
How moving averages guide NovaBay Pharmaceuticals Inc. tradingMarket Trend Summary & Community Verified Trade Signals - Newser
What’s the recovery path for long term holders of NovaBay Pharmaceuticals Inc.Trade Exit Summary & High Return Trade Opportunity Guides - Newser
Tools to monitor NovaBay Pharmaceuticals Inc. recovery probabilityWeekly Loss Report & Risk Adjusted Swing Trade Ideas - Newser
What the charts say about NovaBay Pharmaceuticals Inc. today2025 Major Catalysts & Weekly High Return Opportunities - Newser
Combining machine learning predictions for NovaBay Pharmaceuticals Inc.Inflation Watch & Weekly Stock Breakout Alerts - Newser
Using economic indicators to assess NovaBay Pharmaceuticals Inc. potentialLong Setup & Advanced Technical Analysis Signals - Newser
NovaBay Pharmaceuticals Inc. stock chart pattern explained2025 Institutional Moves & Accurate Entry/Exit Alerts - Newser
Real time alert setup for NovaBay Pharmaceuticals Inc. performance2025 Historical Comparison & Growth Oriented Trade Recommendations - Newser
Predicting NovaBay Pharmaceuticals Inc. trend using moving averages2025 AllTime Highs & Weekly High Return Opportunities - Newser
How to build a custom watchlist for NovaBay Pharmaceuticals Inc.Trade Entry Summary & Precise Buy Zone Identification - Newser
Using data tools to time your NovaBay Pharmaceuticals Inc. exitJuly 2025 Movers & Daily Risk Controlled Trade Plans - Newser
Advanced analytics toolkit walkthrough for NovaBay Pharmaceuticals Inc.July 2025 Opening Moves & Safe Entry Point Alerts - Newser
Novabay Pharmaceuticals (NBY) Soars 98.02% in Three Days on Leadership Shift, $6M Capital Injection - AInvest
Historical volatility pattern of NovaBay Pharmaceuticals Inc. visualized2025 Technical Patterns & Reliable Price Action Trade Plans - Newser
Chart based exit strategy for NovaBay Pharmaceuticals Inc.2025 Market Trends & Long Hold Capital Preservation Plans - Newser
Using Bollinger Bands to evaluate NovaBay Pharmaceuticals Inc.Trade Performance Summary & Growth Focused Stock Pick Reports - Newser
What to do if you’re stuck in NovaBay Pharmaceuticals Inc.Product Launch & Real-Time Stock Movement Alerts - Newser
NovaBay Inks $6M Deal, Appoints New CEO David Lazar - timothysykes.com
Can technical indicators confirm NovaBay Pharmaceuticals Inc.’s reversal2025 Market Overview & Daily Price Action Insights - Newser
Will NovaBay Pharmaceuticals Inc. stock recover after recent dropWatch List & AI Driven Stock Price Forecasts - Newser
Novabay Pharmaceuticals shares rise 6.12% intraday after announcing $0.80 special cash dividend and $6 million securities purchase agreement. - AInvest
NovaBay’s CEO Shakeup: A Bold New Direction? - StocksToTrade
Novabay Pharmaceuticals Inc Azioni (NBY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.96%
1.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):